Tilray Brands (TLRY) Net Margin (2017 - 2026)

Tilray Brands (TLRY) posted Net Margin of 12.21% for Q1 2026, up 38.98% on a QoQ basis from 20.0% in Q4 2025, and up 41493.0% year-over-year from N/an in Q1 2025.

Tilray Brands (TLRY) Net Margin (2017 - 2026) Analysis & Trends

Tilray Brands' Net Margin history runs 10 years deep, the most recent figure standing at 12.21% for Q1 2026.

  • Quarterly Net Margin rose 41493.0% year-over-year to 12.21% in Q1 2026, while the trailing twelve-month figure through Feb 2026 was 170.18% (down 6791.0% YoY) and the FY2025 annual result came in at 280.88%, down 26326.0% from the prior year.
  • Net Margin was 12.21% for Q1 2026 at Tilray Brands, up from 20.0% in the prior quarter.
  • Across five years, Net Margin topped out at 443.19% in Q2 2023 and bottomed at 821.32% in Q1 2023.
  • A 5-year average of 107.51% and a median of 31.57% in 2023 frame the typical range for Net Margin.
  • Annual changes were most pronounced in 2023 — Net Margin tumbled 85587 bps — and 2024, when it soared 76558 bps.
  • Tilray Brands' Net Margin stood at 59.01% in 2022, then surged by 60 bps to 23.83% in 2023, then slumped by 70 bps to 40.42% in 2024, then soared by 51 bps to 20.0% in 2025, then surged by 39 bps to 12.21% in 2026.
  • Business Quant data shows TLRY's Net Margin at 12.21% in Q1 2026, 20.0% in Q4 2025, and 0.72% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 9.29%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 26.57%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -33.66%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 35.18%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 5.03%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 24.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 4.16%
10 Tilray Brands 465.02 Mn 373.06 Mn 54.95 Mn -12.21%

Historic Data

Download Data
DateValue
Feb 28, 2026 -12.21%
Nov 30, 2025 -20.00%
Aug 31, 2025 0.72%
May 31, 2025 -620.57%
Feb 28, 2025 -427.14%
Nov 30, 2024 -40.42%
Aug 31, 2024 -17.32%
May 31, 2024 29.60%
Feb 29, 2024 -55.74%
Nov 30, 2023 -23.83%
Aug 31, 2023 -31.57%
May 31, 2023 443.19%
Feb 28, 2023 -821.32%
Nov 30, 2022 -59.01%
Aug 31, 2022 -42.94%
May 31, 2022 -163.59%
Feb 28, 2022 34.55%
Nov 30, 2021 3.74%
Aug 31, 2021 -20.59%
May 31, 2021 243.19%